Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome
Department
Internal Medicine
Additional Department
Oncology and Hematology
Document Type
Article
Publication Title
American Journal of Hematology
First Page
2241
Last Page
2243
DOI
10.1002/ajh.27461
Volume
99
Issue
11
Publication Date
11-1-2024
Medical Subject Headings
Humans; Kidney Transplantation; Atypical Hemolytic Uremic Syndrome (drug therapy); Remission Induction; Antibodies, Monoclonal, Humanized (therapeutic use); Male; Female; Complement Inactivating Agents (therapeutic use); Adult; Complement C5 (antagonists & inhibitors)
PubMed ID
39177420
Recommended Citation
Mostafa, M. A., Zand, M., Taylor, J., & Kouides, P. (2024). Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome. American Journal of Hematology, 99 (11), 2241-2243. https://doi.org/10.1002/ajh.27461
COinS